. >> coming up, pfizer in pursuit of after zeneca.ising. >> the first day pfizer could ruin new a bid. remind us why they had? >> they abandoned the offer for astrazeneca and, according to our rules, you can come back if you were invited act to the table -- back to the table. that is pretty unlikely. they were opposed to the bid and they wanted increases if they were going to acquiesce. they were oldish on the pipeline. you would have to have a bid. there is another way they could come back. offer.e knockout it would ensure that they have a good idea. how much could that be? remember. the bid was on the table and they did not want to go higher. asterisk zeneca said, no. that is another 3-4 pounds they have to come up with per share. it was not enough. they have to stretch higher. that is what is being debated. approachzer made the to ask her zeneca -- astrazeneca , the love affair continues. they have been eyeing up activists. remember the key reasons why pfizer wants the deal. rate to at the tax lower potential amount by read re-domi

and a one hundred seventeen billion dollar bid that was rejected by astra zeneca shareholders here in the u.k. but they're still trying pfizer c.e.o. still hunting for deals and willing to go big this is c.e.o. ian reed and he says there's no substantial advantage.

and one hundred seventeen billion dollars bid that was rejected by astra zeneca shareholders here in the u.k. but they're still.

and one hundred seventeen billion dollars bid that was rejected by astra zeneca shareholders here in the u.k. but they're still trying pfizer c.e.o. still hunting for deals and willing to go big this is c.e.o. ian reed and he says there's no substantial advantage to being a u.s. company to doing business in the u.s. we are at a tremendous competitive advantage if that's not a sign of end of empire i don't know what is you know it's a shock to headline for him to say there's no upside to being an american company and it goes it's the reality of the situation that there is to be an american company there is no upside to be an american that's why a lot of americans are trying to get rid of their american passport the whole idea of america as offering something.

and one hundred seventeen billion dollars bid that was rejected by astra zeneca shareholders here in the u.k. but they're still trying pfizer c.e.o. still hunting for deals and willing to go big this is c.e.o. ian reed and he says there's no substantial advantage to being a u.s. company to doing business in the u.s. we are at a tremendous competitive advantage if that's not a sign of end of empire i don't know what is you know it's a shocking headline for him to say there's no upside to being an american company and it goes it's the reality of the situation that there is no upside to be an american company there is no upside to being american that's why a lot of americans are trying to get rid of their american passport the whole idea of america as offering something special is to put the c.e.o. of pfizer saying this there's we took everything we could take we extract it all the the infrastructure gains and the subsidies and now there's no upside left we chewed all the meat off the bone so we're going to leave and i think a lot of people tell me this realisation that the myth of amer

well, on behalf -- before we have a drawing, most of the idea zeneca and. we appreciate you take time out to come to birmingham, alabama. many of us did not have a deep notion about nell harper lee. he did it in a thoughtful manner, a respectful manner. i feel much better having read it in thank you for your gift to the literary world. thank you to the press. refer we thank all of you for coming, somebody is really going to be happy. before she draws the name and before everybody is not because she didn't call yours, let's tell the young lady how much we appreciate her. >> thank you. caught back >> thank you so much. thank you. [applause] >> at the georgetown person wins. they are strict libere seat numbers. >> i will not look and i will pull from the middle. >> okay. well first, read the road. >> already. we will do with this was some drama appropriate to the theater. >> the row that has the winner is quite >> the row is jay. >> albright. seat number? feedback are you ready? all rights. row jay, seat 26. yea. [applause] >> this is for you, row j, seat 26.